📰 Dexcom News
Page 87 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
February 4, 2024
Oppenheimer & Co. Inc. lowered its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,218 shares of the medical device company’s stock after selling 518 shares during the period. […]
January 30, 2024
Zions Bancorporation N.A. grew its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,448 shares of the medical device company’s stock after acquiring an additional 801 shares during the quarter. […]
January 29, 2024
Savant Capital LLC lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 111,061 shares of the medical device company’s stock after selling 831 shares during the quarter. Savant Capital LLC’s holdings in DexCom were worth $10,362,000 as of its most […]
January 29, 2024
HM Payson & Co. grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.5% during the third quarter, Holdings Channel reports. The firm owned 1,480 shares of the medical device company’s stock after purchasing an additional 116 shares during the period. HM Payson & Co.’s holdings in DexCom were worth $138,000 as of […]
January 29, 2024
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fourteen analysts that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the […]
January 29, 2024
HM Payson & Co. raised its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,480 shares of the medical device company’s stock after buying an additional 116 shares during the quarter. HM […]
January 28, 2024
Assenagon Asset Management S.A. raised its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1,127.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 385,295 shares of the medical device company’s stock after acquiring an additional 353,901 shares during the period. […]
January 28, 2024
Assenagon Asset Management S.A. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1,127.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 385,295 shares of the medical device company’s stock after acquiring an additional 353,901 shares during the period. Assenagon Asset Management S.A.’s holdings in DexCom were worth $35,948,000 at […]
January 28, 2024
MGO One Seven LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,029 shares of the medical device company’s stock after selling 205 […]
January 27, 2024
DexCom (NASDAQ:DXCM – Free Report) had its target price lifted by Raymond James from $147.00 to $151.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a strong-buy rating on the medical device company’s stock. A number of other research analysts have also commented on DXCM. Piper Sandler upped their price target […]